Novel scar-free robotic technology may define a new standard in minimally invasive surgery. EndoQuest's novel scar-free ...

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...

Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) The planned clinical study will be executed ...

Nattawat Klomjit, MD, shares insights on managing IgA nephropathy and C3 glomerulopathy, including innovative drugs that target kidney inflammation and proteinuria.

MSD has secured an exclusive worldwide license from LaNova Medicines for developing, manufacturing, and commercialising the ...

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some ...

RESEARCHERS from SINTEF have developed a “simpler” low-cost carbon capture and storage (CCS) system for sequestering ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

CRISPR Therapeutics (NASDAQ: CRSP) made a name for itself by pioneering advanced gene therapies made with technologies that ...